Pregnancy Is Associated With a Reduction in the Pattern of the Cytotoxic Activity Displayed by Lymphokine‐Activated Killer Cells
- 1 December 1991
- journal article
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 26 (4) , 150-155
- https://doi.org/10.1111/j.1600-0897.1991.tb00716.x
Abstract
Several modifications in the homeostasis of the maternal immune system have been implicated in the survival of the fetoplacental graft. We have investigated the adaptive response of the cytotoxic nonmajor histocompatibility complex (MHC) ‐restricted effector lymphocytes in pregnancy, and have found that the spontaneous lytic activity against both natural killer (NK)‐sensitive and NK‐resistant target cells is either decreased or lacking in peripheral blood mononuclear cells (PBMNC) from pregnant women. Recombinant interleukin‐2 (rIL‐2) normalizes the cytotoxic activity of PBMNC from pregnant women against NK‐sensitive target cells in a dose‐ and time‐dependent manner, without modification in the normal amounts of HNK‐1+, CD16+ (Leu 11), or CD11b+ (OKM‐1) present in these effector populations. However, the pattern of lytic activity against NK‐resistant target cells found in PBMNC from pregnant women after short‐ and long‐term incubation with rIL‐2 was reduced in comparison with that observed in PBMNC from nongravid women in similar conditions. Moreover, rIL‐2 incubation of PBMNC from pregnant subjects was not associated with an enhancement of the lytic binding against NK‐resistant target cells. These findings demonstrate that pregnancy is not only associated with a reduction in the NK lytic activity of PBMNC, but also with a reduction in the generation of lymphokine‐activated killer activity, in terms of the pattern of lytic activity developed.Keywords
This publication has 19 references indexed in Scilit:
- Human trophoblast and JEG choriocarcinoma cells are sensitive to lysis by IL-2-stimulated decidual NK cellsCellular Immunology, 1990
- Activation of maternal killer cells in the pregnant uterus with chronic indomethacin therapy, IL-2 therapy, or a combination therapy is associated with embryonic demiseCellular Immunology, 1990
- Decreased TcR‐CD3+ T cell numbers in healthy aged humans. Evidence that T cell defects are masked by a reciprocal increase of TcR‐CD3−CD2+ natural killer cellsEuropean Journal of Immunology, 1988
- Diminished Natural Killer Activity in Pregnancy: Modulation by Interleukin 2 and Interferon γScandinavian Journal of Immunology, 1987
- Clinical signification of natural killer activity in B‐cell chronic lymphocytic leukemiaEuropean Journal of Haematology, 1987
- Lymphokine-activated killer cells. Analysis of progenitors and effectors.The Journal of Experimental Medicine, 1986
- Human natural killer cell lysis of virus‐infected cells. Relationship to expression of the transferrin receptorEuropean Journal of Immunology, 1986
- Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cellsThe Journal of Experimental Medicine, 1983
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Natural killer cells mediate lysis of embryonal carcinoma cells lacking MHCNature, 1980